[1] Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 1996, 84:587-597. [2] Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A,1997, 94:13771-13776. [3] 王允,周清华,张尚福,等.肺癌FHIT基因表达下降的临床病理生理意义及与肿瘤细胞增殖、凋亡的关系研究.中华医学遗传学杂志,2001,13:178-182. [4] Capuzzi D, Santoro E, Hauck WW, et al. Fhit expression in gastric adenocarcinoma:correlation with disease stage and survival. Cancer,2000, 88:24-34. [5] Ji L, Fang B, Yen N, et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-nediated fragile histidine triad (FHIT) gene overexpression. Cancer Res,1999, 59:3333-3339. [6] Sard L, Accornero P, Tornielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci U S A, 1999, 96:8489-8492. [7] Mady HH, Melhem MF. FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma:an immunohistochemical and image analysis study.Clin Exp Metastasis, 2002, 19:351-358 |